OssDsign AB (Publ) announced that the company has been awarded a new group purchasing (GPO) agreement for Bone and Bone Substitute Implantable Products with Premier Inc. The agreement is for a period of three years. Effective July 1, 2024, the agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for OssDsign's nanosynthetic bone graft OssDsign Catalyst.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.61 SEK | +0.73% | +5.37% | +20.12% |
May. 14 | Transcript : OssDsign AB, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OssDsign AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.12% | 88.44M | |
+13.20% | 130B | |
-8.74% | 10.99B | |
-5.82% | 8.35B | |
+42.31% | 5.67B | |
-25.76% | 4.72B | |
+7.26% | 3.42B | |
-11.62% | 2.76B | |
-14.30% | 1.92B | |
-30.16% | 1.68B |
- Stock Market
- Equities
- OSSD Stock
- News OssDsign AB
- OssDsign AB Wins Long-Term Agreement with Premier, Inc